FDA points to decline in drug review times in 1995
Am J Health Syst Pharm
.
1996 Mar 1;53(5):473-4, 476.
doi: 10.1093/ajhp/53.5.473.
PMID:
8697005
DOI:
10.1093/ajhp/53.5.473
No abstract available
Publication types
News
MeSH terms
Drug Approval / legislation & jurisprudence*
Investigational New Drug Application
United States
United States Food and Drug Administration*